Figures & data
Table 1. Baseline characteristics and surgical details of patients with a hip fracture treated with a total hip arthroplasty (THA) or a hemiarthroplasty (HA)
Figure 1. Cumulative incidence function (CIF) of revision estimates from competing risks data (1 – survival) for patients treated with HA and THA (n = 30,830).
![Figure 1. Cumulative incidence function (CIF) of revision estimates from competing risks data (1 – survival) for patients treated with HA and THA (n = 30,830).](/cms/asset/5caa2b60-acf9-4222-a12b-02fff8579a18/iort_a_1499069_f0001_c.jpg)
Table 2. Cumulative incidence function (CIF) estimates from competing risks data (1-survival) for patients treated with HA and THA
Table 3. Reasons for revision after hemiarthroplasty (HA) or total hip arthroplasty (THA) for hip fractures
Table 4. Factors associated with revision in hip fracture patients after hemiarthroplasty (HA) and total hip arthroplasty (THA) in a univariable analysis with a hazard analysis
Table 5. Factors associated with revision in hip fracture treated with a total hip arthroplasty (THA) or a hemiarthroplasty (HA) in a multivariable approach with hazards model with time-varying covariables
Table 6. Reason for revision in factors associated with revision in hip fracture treated with a total hip arthroplasty (THA) or a hemiarthroplasty (HA)